89bio Inc Stock Performance
| ETNB Stock | USD 8.99 0.15 1.64% |
89bio has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.74, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 89bio will likely underperform. 89bio Inc at this time shows a risk of 3.94%. Please confirm 89bio Inc sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if 89bio Inc will be following its price patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 89bio may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
Actual Historical Performance (%)
One Day Return (1.64) | Five Day Return (1.53) | Year To Date Return (20.37) | Ten Year Return (56.78) | All Time Return (56.78) |
1 | Disposition of 16527 shares by Rohan Palekar of 89bio at 18.95 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 5352 shares by Le-nguyen Quoc of 89bio at 8.46 subject to Rule 16b-3 | 09/09/2024 |
3 | Disposition of 9671 shares by Mansbach Harry H of 89bio at 11.53 subject to Rule 16b-3 | 09/27/2024 |
4 | Acquisition by Le-nguyen Quoc of 8334 shares of 89bio subject to Rule 16b-3 | 10/14/2024 |
5 | State Street Corps Strategic Acquisition in 89bio Inc | 10/17/2024 |
6 | Disposition of 27955 shares by Le-nguyen Quoc of 89bio at 8.12 subject to Rule 16b-3 | 10/30/2024 |
7 | 89bios chief technical operations officer sells 226,994 in stock | 11/01/2024 |
8 | Raymond James Issues Pessimistic Forecast for 89bio Stock Price - MarketBeat | 11/08/2024 |
9 | 89bio Upsizes Public Offering to Raise 125 Million, Offering 11.5 Million Shares and Warrants | 11/13/2024 |
10 | Acquisition by Ra Capital Management, L.p. of 3250000 shares of 89bio at 0.001 subject to Rule 16b-3 | 11/14/2024 |
11 | Biotechnology Value Fund L.P. Reduces Stake in 89bio Inc | 11/15/2024 |
12 | Acquisition by Rohan Palekar of 10000 shares of 89bio at 8.35 subject to Rule 16b-3 | 11/22/2024 |
13 | 89bio to Participate in the 7th Annual Evercore HealthCONx Conference | 11/26/2024 |
14 | 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 11/29/2024 |
| Begin Period Cash Flow | 55.3 M | |
| Free Cash Flow | -129.2 M |
89bio |
89bio Relative Risk vs. Return Landscape
If you would invest 878.00 in 89bio Inc on September 2, 2024 and sell it today you would earn a total of 21.00 from holding 89bio Inc or generate 2.39% return on investment over 90 days. 89bio Inc is currently generating 0.1114% in daily expected returns and assumes 3.9443% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than 89bio, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
89bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 89bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as 89bio Inc, and traders can use it to determine the average amount a 89bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0283
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ETNB | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average 89bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 89bio by adding it to a well-diversified portfolio.
89bio Fundamentals Growth
89bio Stock prices reflect investors' perceptions of the future prospects and financial health of 89bio, and 89bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 89bio Stock performance.
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.41 | ||||
| Current Valuation | 670.86 M | ||||
| Shares Outstanding | 117.58 M | ||||
| Price To Earning | (1.04) X | ||||
| Price To Book | 2.80 X | ||||
| EBITDA | (134.46 M) | ||||
| Net Income | (142.19 M) | ||||
| Cash And Equivalents | 193.34 M | ||||
| Cash Per Share | 4.16 X | ||||
| Total Debt | 27.11 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 3.56 X | ||||
| Cash Flow From Operations | (129.19 M) | ||||
| Earnings Per Share | (2.96) X | ||||
| Market Capitalization | 1.07 B | ||||
| Total Asset | 596.27 M | ||||
| Retained Earnings | (457.43 M) | ||||
| Working Capital | 563.92 M | ||||
| Current Asset | 10.12 M | ||||
| Current Liabilities | 3.89 M | ||||
About 89bio Performance
By analyzing 89bio's fundamental ratios, stakeholders can gain valuable insights into 89bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 89bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 89bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.24) | (0.25) | |
| Return On Capital Employed | (0.27) | (0.28) | |
| Return On Assets | (0.24) | (0.25) | |
| Return On Equity | (0.27) | (0.28) |
Things to note about 89bio Inc performance evaluation
Checking the ongoing alerts about 89bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 89bio Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 89bio Inc had very high historical volatility over the last 90 days | |
| Net Loss for the year was (142.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 89bio Inc currently holds about 193.34 M in cash with (129.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.16. | |
| 89bio Inc has a frail financial position based on the latest SEC disclosures | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635 |
- Analyzing 89bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 89bio's stock is overvalued or undervalued compared to its peers.
- Examining 89bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 89bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 89bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 89bio's stock. These opinions can provide insight into 89bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 89bio Stock analysis
When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |